July 20 (Reuters) - Futures tracking the S&P 500 and Dow
indexes pared early declines to trade marginally higher, as
hopes of a coronavirus vaccine offset concerns about the
economic damage from a surge in domestic COVID-19 infections.
German biotech firm BioNTech BNTX.O and U.S. drugmaker
Pfizer PFE.N reported additional data from their experimental
coronavirus vaccine that showed the vaccine was safe and induced
an immune response in patients. At 9:01 a.m. ET, Dow e-minis 1YMcv1 were up 15 points, or
0.06%, and S&P 500 e-minis EScv1 were up 1.25 points, or
0.04%. Nasdaq 100 e-minis NQcv1 , which were up before the
report, hit session highs.